Minor early changes in lungs can signal changes in progressive lung disease
The research focused on the very early stages of FPF, a serious progressive lung disease where for unknown reasons scar tissue builds up in the lungs over time.
Scott Mcall, MD, PhD, among six Vanderbilt Faculty Research Scholars named
Six junior faculty and postdoctoral fellows have been appointed this year to the Vanderbilt Faculty Research Scholars (VFRS) program at Vanderbilt University Medical Center.
Cell-specific variations in gene regulation may be key to treating pulmonary fibrosis
An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis.
Four physician-scientists from VUMC receive national early-career awards
Four Vanderbilt physician-scientists have received awards from the American Society for Clinical Investigation, including VTACC's Debra Dixon, MD, MS, instructor in the Division of Cardiovascular…
New target for lung fibrosis
Blocking thromboxane-prostanoid receptor signaling protected animals from lung fibrosis in preclinical models, suggesting a new treatment for IPF — a chronic, progressive lung disorder that often…